This article provides the first extensive documentation of the dose response features of pre-
and postconditioning. Pre-and postconditioning studies with rigorous study designs, using …

Studies in genetically modified mice have demonstrated that neuregulin-1 (NRG-1), along
with the erythroblastic leukemia viral oncogene homolog (ErbB) 2, 3, and 4 receptor tyrosine …

Drawing on firsthand observations, Party and government documents, and survey data, this
study examines the causes and processes of the land for welfare policy in China. The …

NRG1 (Neuregulin-1) is an effective cardiomyocyte proliferator, secreted and released by
endothelial vascular cells, and affects the cardiovascular system. It plays a major role in …

Neuregulins (NRGs) are protein ligands that act through ErbB receptor tyrosine kinases to
regulate tissue morphogenesis, plasticity, and adaptive responses to physiologic needs in …

Hemodynamic shear forces are intimately linked with cardiac development, during which
trabeculae form a network of branching outgrowths from the myocardium. Mutations that …

Heart failure is a complex syndrome whose phenotypic presentation and disease
progression depends on a complex network of adaptive and maladaptive responses. One of …

Neuregulin-1 (NRG-1) and its signaling receptors, erythroblastic leukemia viral oncogene
homologs (ErbB) 2, 3, and 4, have been implicated in both cardiomyocyte development and …

Doxorubicin (DOX) is used as a chemotherapeutic agent in the treatment of solid tumors.
Irreversible cardiotoxicity is the major limitation in the clinical use of DOX. Several …

The dual role of ErbB2 (or HER-2) in tumor growth and in physiological adaptive reactions of
the heart positions ErbB2 at the intersection between cancer and chronic heart failure …